Patient Capital Management, LLC Precigen, Inc. Transaction History
Patient Capital Management, LLC
- $1.86 Billion
- Q3 2024
A detailed history of Patient Capital Management, LLC transactions in Precigen, Inc. stock. As of the latest transaction made, Patient Capital Management, LLC holds 17,937,694 shares of PGEN stock, worth $14.7 Million. This represents 0.92% of its overall portfolio holdings.
Number of Shares
17,937,694
Previous 18,174,658
1.3%
Holding current value
$14.7 Million
Previous $28.7 Million
40.66%
% of portfolio
0.92%
Previous 1.57%
Shares
9 transactions
Others Institutions Holding PGEN
# of Institutions
144Shares Held
159MCall Options Held
232KPut Options Held
69K-
Third Security, LLC83.5MShares$68.4 Million73.5% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA10.9MShares$8.91 Million0.02% of portfolio
-
Black Rock Inc. New York, NY10.2MShares$8.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.33MShares$6.83 Million0.0% of portfolio
-
Iridian Asset Management LLC3.78MShares$3.1 Million0.8% of portfolio
About PRECIGEN, INC.
- Ticker PGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 208,150,000
- Market Cap $171M
- Description
- Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...